OtherCardiovascular
Sulodexide (KRX-101) Attenuates Myocardial Ischemia/Reperfusion Injury and the Deposition of C-Reactive Protein in Areas of Infarction without Affecting Hemostasis
D. Adam Lauver, Erin A. Booth, Andrew J. White, Enrique Poradosu and Benedict R. Lucchesi
Journal of Pharmacology and Experimental Therapeutics September 13, 2004, DOI: https://doi.org/10.1124/jpet.104.075283
D. Adam Lauver
Erin A. Booth
Andrew J. White
Enrique Poradosu
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherCardiovascular
Sulodexide (KRX-101) Attenuates Myocardial Ischemia/Reperfusion Injury and the Deposition of C-Reactive Protein in Areas of Infarction without Affecting Hemostasis
D. Adam Lauver, Erin A. Booth, Andrew J. White, Enrique Poradosu and Benedict R. Lucchesi
Journal of Pharmacology and Experimental Therapeutics September 13, 2004, DOI: https://doi.org/10.1124/jpet.104.075283
OtherCardiovascular
Sulodexide (KRX-101) Attenuates Myocardial Ischemia/Reperfusion Injury and the Deposition of C-Reactive Protein in Areas of Infarction without Affecting Hemostasis
D. Adam Lauver, Erin A. Booth, Andrew J. White, Enrique Poradosu and Benedict R. Lucchesi
Journal of Pharmacology and Experimental Therapeutics September 13, 2004, DOI: https://doi.org/10.1124/jpet.104.075283
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement